Additionally, many of the currently available clinical agents display the always on characteristic, where they illuminate disease sites through self-accumulation rather than being specifically activated by target molecules of interest, which leads to poor imaging contrast and compromised detection accuracy
Cureus 16(8): e67232
Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimers disease and dementia: New evidence, potential therapeutic strategies, and biomarkers
The test maps 14 metabolic pathways and 150+ genetic insights related to weight regulation and peptide response, empowering a truly personalized treatment plan
Similar experimental results have also been confirmed in the mouse model of hepatocellular carcinoma, which indicates that PLC-1-related Ang II/AT1R/CaM signal is an important mechanism to promote the migration and invasion of HCC cells ( 3.2 CD133, EMT markers and miR-146a PLC-2 is expressed in most breast tumors, and its level can affect the prognosis of patients ( Triple-negative breast cancer (TNBC), which accounts for about 20% of all breast tumors, is a highly malignant tumor with a particularly poor prognosis
Acetyl-L-Carnitine in Neuropathic Pain Experimental Data Santina Chiechio Agata Copani Robert W Gereau Ferdinando Nicoletti Acetyl-L-carnitine (ALC) has gained clinical interest for its analgesic effect in different forms of neuropathies associated with chronic pain, such as diabetic and HIV-related peripheral neuropathies